Atlanta, GA, United States of America

Xun Yang

This inventor holds 1 USPTO granted patent. Top assignees: Children's Healthcare of Atlanta, Inc., Emory University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xun Yang. Retrieved from https://idiyas.com/inventor/xun-yang-10od8fqt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Xun Yang

Introduction

Xun Yang is a notable inventor based in Atlanta, GA, who has made significant contributions to the field of pharmaceutical sciences. His work primarily focuses on developing modulators for the cystic fibrosis transmembrane conductance regulator (CFTR), which plays a crucial role in managing cystic fibrosis and related respiratory conditions.

Latest Patents

Xun Yang holds a patent for "Cystic fibrosis transmembrane conductance regulator (CFTR) modulators, pharmaceutical compositions, and uses thereof." This patent relates to compounds that act as CFTR modulators and includes pharmaceutical compositions containing these compounds. The disclosure outlines methods for managing CFTR-related diseases or conditions by administering effective amounts of the CFTR modulators to individuals in need.

Career Highlights

Throughout his career, Xun Yang has worked with prestigious institutions such as Emory University and Children's Healthcare of Atlanta, Inc. His research has significantly advanced the understanding and treatment of cystic fibrosis, showcasing his dedication to improving patient outcomes.

Collaborations

Xun Yang has collaborated with esteemed colleagues, including Eric Sorscher and Haian Fu, to further his research and innovations in the field of cystic fibrosis treatment.

Conclusion

Xun Yang's contributions to the development of CFTR modulators highlight his commitment to advancing medical science and improving the lives of those affected by cystic fibrosis. His innovative work continues to pave the way for future advancements in pharmaceutical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…